SyntekaBio Inc Total Liabilities

Latest as of March 2026: ₩15.35 Billion KRW ≈ $10.40 Million USD

SyntekaBio Inc total liabilities. Based on the latest financial reports, SyntekaBio Inc (226330) has total liabilities worth ₩15.35 Billion KRW (≈ $10.40 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check SyntekaBio Inc (226330) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of SyntekaBio Inc (2017–2025)

Total liabilities of SyntekaBio Inc from 2017 to 2025. This chart illustrates how SyntekaBio Inc's total liabilities have evolved over time, based on quarterly financial data.

SyntekaBio Inc Competitors by Total Liabilities

The table below lists competitors of SyntekaBio Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Marti Otel Isletmeleri AS IS:MARTI	Turkey	TL9.74 Billion
Everest Metals Corporation Ltd AU:EMC	Australia	AU$1.66 Million
Pensonic Holdings Bhd KLSE:9997	Malaysia	RM156.31 Million
Alpha Microelectronics TWO:8024	Taiwan	NT$35.14 Million
Locksley Resources Ltd AU:LKY	Australia	AU$1.07 Million
Neuphoria Therapeutics Inc NASDAQ:NEUP	USA	$4.11 Million
OURGAME INT.HOL.DL-00005 F:13O	Germany	€34.30 Million
Baid Finserv Limited NSE:BAIDFIN	India	Rs2.95 Billion

Liability Composition Analysis (2017–2025)

This chart breaks down SyntekaBio Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see SyntekaBio Inc (226330) total assets.

Liquidity & Leverage Metrics

SyntekaBio Inc Total Liabilities Ratios Explained

SyntekaBio Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.16	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.54	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.35	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how SyntekaBio Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for SyntekaBio Inc (2017–2025)

The table below shows the annual total liabilities of SyntekaBio Inc from 2017 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩14.76 Billion ≈ $10.00 Million	-21.39%
2024-12-31	₩18.77 Billion ≈ $12.72 Million	-13.45%
2023-12-31	₩21.69 Billion ≈ $14.70 Million	-10.48%
2022-12-31	₩24.23 Billion ≈ $16.42 Million	-39.81%
2021-12-31	₩40.25 Billion ≈ $27.28 Million	+1143.18%
2020-12-31	₩3.24 Billion ≈ $2.19 Million	+76.39%
2019-12-31	₩1.84 Billion ≈ $1.24 Million	-82.46%
2018-12-31	₩10.47 Billion ≈ $7.09 Million	+97.70%
2017-12-31	₩5.29 Billion ≈ $3.59 Million	--

About SyntekaBio Inc

KQ:226330 Korea Health Information Services

Market Cap

$16.19 Million

₩23.89 Billion KRW

Market Cap Rank

#25595 Global

#1899 in Korea

Share Price

₩985.00

Change (1 day)

-0.71%

52-Week Range

₩985.00 - ₩5900.00

All Time High

₩43250.00